The new era of treatment for obesity and metabolic disorders: Evidence and expectations for gut microbiome transplantation

Frontiers in Cellular and Infection Microbiology

Volumn 6, Issue FEB, 2016, Pages

  Jayasinghe, Thilini N ^a   Chiavaroli, Valentina ^a   Holland, David J ^b   Cutfield, Wayne S ^a,c   O'Sullivan, Justin M ^a,c  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Counties Manukau Health ^*  (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Gut microbiome transplantation; Microbiome; Microbiota; Obesity; Treatment

Indexed keywords

GENE INTERACTION; HUMAN; INTESTINE FLORA; LIFESTYLE MODIFICATION; METABOLIC DISORDER; MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROBIAL GROWTH; NONHUMAN; OBESITY; ORGAN TRANSPLANTATION; REVIEW; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL TRACT; METABOLIC DISEASES; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES;

PROBIOTIC AGENT;

FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; METABOLIC DISEASES; OBESITY; PROBIOTICS;

EID: 85006190125     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2016.00015     Document Type: Review

References (144)

1. Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., and Versalovic, J. (2014). The placenta harbors a unique microbiome. Sci. Transl. Med. 6, 237ra65. doi: 10.1126/scitranslmed.3008599
2. Alang, N., and Kelly, C. R. (2015). Weight gain after fecal microbiota transplantation. Open Forum Infect. Dis. 2:ofv004. doi: 10.1093/ofid/ofv004
3. Andrews, P., Borody, T., Shortis, N., and Thompson, S. (1995). Bacteriotherapy for chronic constipation-a long term follow-up. Gastroenterology 108, A563.
4. Armougom, F., Henry, M., Vialettes, B., Raccah, D., and Raoult, D. (2009). Monitoring bacterial community of human gut microbiota reveals an increase in lactobacillus in obese patients and methanogens in anorexic patients. PLoS ONE 4:e7125. doi: 10.1371/journal.pone.0007125
5. Aroniadis, O. C., and Brandt, L. J. (2013). Fecal microbiota transplantation: past, present and future. Curr. Opin. Gastroenterol. 29, 79-84. doi: 10.1097/MOG.0b013e32835a4b3e
6. Aslam, Z., Yasir, M., Khaliq, A., Matsui, K., and Chung, Y. R. (2010). Too much bacteria still unculturable. Crop Environ. 1, 59-60.
7. Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., et al. (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 101, 15718-15723. doi: 10.1073/pnas.0407076101
8. Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., and Gordon, J. I. (2005). Host-bacterial mutualism in the human intestine. Science 307, 1915-1920. doi: 10.1126/science.1104816
9. Backhed, F., Manchester, J. K., Semenkovich, C. F., and Gordon, J. I. (2007). Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U.S.A. 104, 979-984. doi: 10.1073/pnas.0605374104
10. Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A., et al. (2011). Treating Clostridium difficile infection with fecal microbiota transplantation. Clin. Gastroenterol. Hepatol. 9, 1044-1049. doi: 10.1016/j.cgh.2011.08.014
11. Berg, R. D., Wommack, E., and Deitch, E. A. (1988). Immunosuppression and intestinal bacterial overgrowth synergistically promote bacterial translocation. Arch Surg. 123, 1359-1364. doi: 10.1001/archsurg.1988.01400350073011
12. Bergman, E. N. (1990). Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol. Rev. 70, 567-590.
13. Bervoets, L., Van Hoorenbeeck, K., Kortleven, I., Van Noten, C., Hens, N., Vael, C., et al. (2013). Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog. 5:10. doi: 10.1186/1757-4749-5-10
14. Binns, N. (2013). Probiotics, Prebiotics and the GUT Microbiota. Available online at: http://www.ilsi.org/Europe/Publications/Prebiotics-Probiotics.pdf
15. Blustein, J., and Liu, J. (2015). Time to consider the risks of caesarean delivery for long term child health. BMJ 350:h2410. doi: 10.1136/bmj.h2410
16. Borody, T. J., and Khoruts, A. (2012). Fecal microbiota transplantation and emerging applications. Nat. Rev. Gastroenterol. Hepatol. 9, 88-96. doi: 10.1038/nrgastro.2011.244
17. Borody, T., Peattie, D., and Mitchell, S. (2015). Fecal microbiota transplantation: expanding horizons for Clostridium difficile Infections and Beyond. Antibiotics 4, 254-266. doi: 10.3390/antibiotics4030254
18. Brandt, L. J. (2012). Editorial commentary: fecal microbiota transplantation: patient and physician attitudes. Clin. Infect. Dis. 55, 1659-1660. doi: 10.1093/cid/cis812
19. Brandt, L. J. (2013). American journal of gastroenterology lecture: intestinal microbiota and the role of fecal microbiota transplant (FMT) in treatment of C. difficile infection. Am. J. Gastroenterol. 108, 177-185. doi: 10.1038/ajg.2012.450
20. Brandt, L. J., Aroniadis, O. C., Mellow, M., Kanatzar, A., Kelly, C., Park, T., et al. (2012). Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am. J. Gastroenterol. 107, 1079-1087. doi: 10.1038/ajg.2012.60
21. Butel, M.-J., Suau, A., Campeotto, F., Magne, F., Aires, J., Ferraris, L., et al. (2007). Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J. Pediatr. Gastroenterol. Nutr. 44, 577-582. doi: 10.1097/MPG.0b013e3180406b20
22. Cani, P. D., and Delzenne, N. M. (2007). Gut microflora as a target for energy and metabolic homeostasis. Curr. Opin. Clin. Nutr. Metab. Care 10, 729-734. doi: 10.1097/MCO.0b013e3282efdebb
23. Clarke, G., Stilling, R. M., Kennedy, P. J., Stanton, C., Cryan, J. F., and Dinan, T. G. (2014). Minireview: Gut microbiota: the neglected endocrine organ. Mol. Endocrinol. 28, 1221-1238. doi: 10.1210/me.2014-1108
24. Collins, M. E. (1988). Education for healthy body weight: helping adolescents balance the cultural pressure for thinness. J. Sch. Health 58, 227-231. doi: 10.1111/j.1746-1561.1988.tb05870.x
25. Colman, R. J., and Rubin, D. T. (2014). Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J. Crohns. Colitis 8, 1569-1581. doi: 10.1016/j.crohns.2014.08.006
26. Colson, P., Fancello, L., Gimenez, G., Armougom, F., Desnues, C., Fournous, G., et al. (2013). Evidence of the megavirome in humans. J. Clin. Virol. 57, 191-200. doi: 10.1016/j.jcv.2013.03.018
27. Conlon, M. A., and Bird, A. R. (2015). The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7, 17-44. doi: 10.3390/nu7010017
28. Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., et al. (2011). Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U.S.A. 108, 3047-3052. doi: 10.1073/pnas.1010529108
29. Dominguez-Bello, M. G., Costello, E. K., Contreras, M., Magris, M., Hidalgo, G., Fierer, N., et al. (2010). Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl. Acad. Sci. U.S.A. 107, 11971-11975. doi: 10.1073/pnas.1002601107
30. Duncan, S. H., Lobley, G. E., Holtrop, G., Ince, J., Johnstone, A. M., Louis, P., et al. (2008). Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. (Lond.) 32, 1720-1724. doi: 10.1038/ijo.2008.155
31. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., et al. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638. doi: 10.1126/science.1110591
32. Eiseman, B., Silen, W., Bascom, G. S., and Kauvar, A. J. (1958). Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44, 854-859.
33. Encinosa, W. E., Bernard, D. M., Steiner, C. A., and Chen, C.-C. (2005). Use and costs of bariatric surgery and prescription weight-loss medications. Health Aff. (Millwood). 24, 1039-1046. doi: 10.1377/hlthaff.24.4.1039
34. Fanaro, S., Chierici, R., Guerrini, P., and Vigi, V. (2007). Intestinal microflora in early infancy: composition and development. Acta Paediatr. 92, 48-55. doi: 10.1111/j.1651-2227.2003.tb00646.x
35. Ferrer, M., Ruiz, A., Lanza, F., Haange, S. B., Oberbach, A., Till, H., et al. (2013). Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ. Microbiol. 15, 211-226. doi: 10.1111/j.1462-2920.2012.02845.x
36. Frank, D. N., St Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., and Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U.S.A. 104, 13780-13785. doi: 10.1073/pnas.0706625104
37. Gebbers, J. O., and Laissue, J. A. (1989). Immunologic structures and functions of the gut. Schweiz. Arch. Tierheilkd. 131, 221-238.
38. Gérard, P. (2015). Gut microbiota and obesity. Cell. Mol. Life Sci. 73, 147-162. doi: 10.1007/s00018-015-2061-5
39. Gerritsen, J., Smidt, H., Rijkers, G. T., and de Vos, W. M. (2011). Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 6, 209-240. doi: 10.1007/s12263-011-0229-7
40. Gloy, V. L., Briel, M., Bhatt, D. L., Kashyap, S. R., Schauer, P. R., Mingrone, G., et al. (2013). Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 347:f5934. doi: 10.1136/bmj.f5934
41. Golan, M., Weizman, A., Apter, A., and Fainaru, M. (1998). Parents as the exclusive agents of change in the treatment of childhood obesity. Am. J. Clin. Nutr. 67, 1130-1135.
42. Goldenberg, R. L., Culhane, J. F., Iams, J. D., and Romero, R. (2008). Epidemiology and causes of preterm birth. Lancet 371, 75-84. doi: 10.1016/S0140-6736(08)60074-4
43. Gorbach, S. L. (1996). "Microbiology of the gastrointestinal tract, " in Medical Microbiology, 4th Edn., ed T. Samuel Baron (Galveston, TX: University of Texas Medical Branch). Available online at: http://www.ncbi.nlm.nih.gov/books/NBK7670/
44. Gough, E., Shaikh, H., and Manges, A. R. (2011). Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53, 994-1002. doi: 10.1093/cid/cir632
45. Harmsen, H. J., Wildeboer-Veloo, A. C., Raangs, G. C., Wagendorp, A. A., Klijn, N., Bindels, J. G., et al. (2000). Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 30, 61-7. doi: 10.1097/00005176-200001000-00019
46. Hartstra, A. V., Bouter, K. E. C., Bäckhed, F., and Nieuwdorp, M. (2014). Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 38, 159-165. doi: 10.2337/dc14-0769
47. Heuer, H., Hartung, K., Wieland, G., Kramer, I., and Braunschweig, D. (1999). Polynucleotide probes that target a hypervariable region of 16S rRNA genes to identify bacterial isolates corresponding to bands of community fingerprints. 65, 1045-1049.
48. Hill, A. J. (2007). Causes and consequences of dieting and anorexia. Proc. Nutr. Soc. 52, 211-218. doi: 10.1079/PNS19930053
49. Hill, A. J., Draper, E., and Stack, J. (1994). A weight on children's minds: body shape dissatisfactions at 9-years old. Int. J. Obes. Relat. Metab. Disord. 18, 383-389.
50. Hota, S. S., Achonu, C., Crowcroft, N. S., Harvey, B. J., Lauwers, A., and Gardam, M. A. (2012). Determining mortality rates attributable to Clostridium difficile infection. Emerg. Infect. Dis. 18, 305-307. doi: 10.3201/eid1802.101611
51. Howitt, M. R., and Garrett, W. S. (2012). A complex microworld in the gut: gut microbiota and cardiovascular disease connectivity. Nat. Med. 18, 1188-1189. doi: 10.1038/nm.2895
52. Hütter, J. F., Schweickhardt, C., Hunneman, D. H., Piper, H. M., and Spieckermann, P. G. (2012). A new method for studying the incorporation of nonesterified fatty acids into cardiac lipids by using deuterium-labelled palmitate. Basic Res. Cardiol. 83, 87-93. doi: 10.1007/BF01907108
53. Jakobsson, H. E., Jernberg, C., Andersson, A. F., Sjölund-Karlsson, M., Jansson, J. K., and Engstrand, L. (2010). Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 5:e9836. doi: 10.1371/journal.pone.0009836
54. Jiménez, E., Fernández, L., Marín, M. L., Martín, R., Odriozola, J. M., Nueno-Palop, C., et al. (2005). Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr. Microbiol. 51, 270-274. doi: 10.1007/s00284-005-0020-3
55. Jiménez, E., Marín, M. L., Martín, R., Odriozola, J. M., Olivares, M., Xaus, J., et al. (2008). Is meconium from healthy newborns actually sterile? Res. Microbiol. 159, 187-193. doi: 10.1016/j.resmic.2007.12.007
56. Jumpertz, R., Le, D. S., Turnbaugh, P. J., Trinidad, C., Bogardus, C., Gordon, J. I., et al. (2011). Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am. J. Clin. Nutr. 94, 58-65. doi: 10.3945/ajcn.110.010132
57. Kassam, Z., Lee, C. H., Yuan, Y., and Hunt, R. H. (2013). Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am. J. Gastroenterol. 108, 500-508. doi: 10.1038/ajg.2013.59
58. Khanna, S., and Tosh, P. K. (2014). A clinician's primer on the role of the microbiome in human health and disease. Mayo Clin. Proc. 89, 107-114. doi: 10.1016/j.mayocp.2013.10.011
59. Kim, B.-S., Jeon, Y.-S., and Chun, J. (2013). Current status and future promise of the human microbiome. Pediatr. Gastroenterol. Hepatol. Nutr. 16, 71-79. doi: 10.5223/pghn.2013.16.2.71
60. Knight, R. (1993). Bacterial Communities as a Theme Linking. Human, Animal and Environmental Health. Available online at: http://iom.nationalacademies.org/~/media/87E9D588D5C44B9999E6839D46D298B6.ashx
61. Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., et al. (2011). Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U.S.A. 108(Suppl.), 4578-4585. doi: 10.1073/pnas.1000081107
62. Kornman, K. S., and Loesche, W. J. (1980). The subgingival microbial flora during pregnancy. J. Periodontal Res. 15, 111-122. doi: 10.1111/j.1600-0765.1980.tb00265.x
63. Kostic, A. D., Gevers, D., Siljander, H., Vatanen, T., Hyötyläinen, T., Hämäläinen, A.-M., et al. (2015). The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17, 260-273. doi: 10.1016/j.chom.2015.01.001
64. Kostic, A. D., Xavier, R. J., and Gevers, D. (2014). The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146, 1489-1499. doi: 10.1053/j.gastro.2014.02.009
65. Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., et al. (2010). Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5:e9085. doi: 10.1371/journal.pone.0009085
66. Lee, J. S., and Polin, R. A. (2003). Treatment and prevention of necrotizing enterocolitis. Semin. Neonatol. 8, 449-459. doi: 10.1016/S1084-2756(03)00123-4
67. Leslie, P., Tzimas, D., Price, J., Mone, A., Hirsh, J., Poles, M., et al. (2014). "Perceptions of fecal microbiota transplantation: factors that predict acceptance, " in James W. Freston Conference, 35-37. Available online at: http://www.gastro.org/pressroom/James_W._Freston_Abstract_Factors_that_Predict_Acceptance.pdf
68. Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., and Gordon, J. I. (2005). Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 102, 11070-11075. doi: 10.1073/pnas.0504978102
69. Ley, R. E., Peterson, D. A., and Gordon, J. I. (2006a). Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 124, 837-848. doi: 10.1016/j.cell.2006.02.017
70. Ley, R. E., Turnbaugh, P. J., Klein, S., and Gordon, J. I. (2006b). Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023. doi: 10.1038/4441022a
71. Li, M., Wang, M., and Donovan, S. M. (2014). Early development of the gut microbiome and immune-mediated childhood disorders. Semin. Reprod. Med. 32, 74-86. doi: 10.1055/s-0033-1361825
72. Lund-Tønnesen, S., Berstad, A., Schreiner, A., and Midtvedt, T. (1998). [Clostridium difficile-associated diarrhea treated with homologous feces]. Tidsskr. den Nor. lægeforening Tidsskr. Prakt. Med. ny række 118, 1027-1030.
73. Lyte, M. (2013). Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog. 9:e1003726. doi: 10.1371/journal.ppat.1003726
74. Macpherson, A. J., and Harris, N. L. (2004). Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4, 478-485. doi: 10.1038/nri1373
75. Maynard, C. L., Elson, C. O., Hatton, R. D., and Weaver, C. T. (2012). Reciprocal interactions of the intestinal microbiota and immune system. Nature 489, 231-241. doi: 10.1038/nature11551
76. Mazmanian, S. K., Liu, C. H., Tzianabos, A. O., and Kasper, D. L. (2005). An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122, 107-118. doi: 10.1016/j.cell.2005.05.007
77. Meyer, F., Paarmann, D., D'souza, M., Olson, R., Glass, E. M., Kubal, M., et al. (2008). The metagenomics RAST server-a public resource for the automatic phylogenetic and functional analysis of metagenomes. BMC Bioinformatics 9:386. doi: 10.1186/1471-2105-9-386
78. Mitsuoka, T. (1990). Bifidobacteria and their role in human health. J. Ind. Microbiol. 6, 263-267. doi: 10.1007/BF01575871
79. Modi, S. R., Collins, J. J., and Relman, D. A. (2014). Antibiotics and the gut microbiota. J. Clin. Invest. 124, 4212-4218. doi: 10.1172/JCI72333
80. Moore, T., Rodriguez, A., and Bakken, J. S. (2014). Fecal microbiota transplantation: a practical update for the infectious disease specialist. Clin. Infect. Dis. 58, 541-545. doi: 10.1093/cid/cit950
81. Mueller, S., Saunier, K., Hanisch, C., Norin, E., Alm, L., Midtvedt, T., et al. (2006). Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 72, 1027-1033. doi: 10.1128/AEM.72.2.1027-1033.2006
82. Munford, R. S. (2008). Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant? Infect. Immun. 76, 454-465. doi: 10.1128/iai.00939-07
83. Mutlu, E. A., Gillevet, P. M., Rangwala, H., Sikaroodi, M., Naqvi, A., Engen, P. A., et al. (2012). Colonic microbiome is altered in alcoholism. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G966-G978. doi: 10.1152/ajpgi.00380.2011
84. Neu, J., and Rushing, J. (2011). Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clin. Perinatol. 38, 321-331. doi: 10.1016/j.clp.2011.03.008
85. Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., et al. (2012). Host-gut microbiota metabolic interactions. Science 336, 1262-1267. doi: 10.1126/science.1223813
86. Ordovas, J. M., and Mooser, V. (2006). Metagenomics: the role of the microbiome in cardiovascular diseases. Curr. Opin. Lipidol. 17, 157-161. doi: 10.1097/01.mol.0000217897.75068.ba
87. Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., and Brown, P. O. (2007). Development of the human infant intestinal microbiota. PLoS Biol. 5:e177. doi: 10.1371/journal.pbio.0050177
88. Panda, S., El Khader, I., Casellas, F., López Vivancos, J., García Cors, M., Santiago, A., et al. (2014). Short-term effect of antibiotics on human gut microbiota. PLoS ONE 9:e95476. doi: 10.1371/journal.pone.0095476
89. Park, S., and Bae, J.-H. (2015). Probiotics for weight loss: a systematic review and meta-analysis. Nutr. Res. 35, 566-575. doi: 10.1016/j.nutres.2015.05.008
90. Penders, J., Thijs, C., Vink, C., Stelma, F. F., Snijders, B., Kummeling, I., et al. (2006). Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511-521. doi: 10.1542/peds.2005-2824
91. Penders, J., Vink, C., Driessen, C., London, N., Thijs, C., and Stobberingh, E. E. (2005). Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breast-fed and formula-fed infants by real-time PCR. FEMS Microbiol. Lett. 243, 141-147. doi: 10.1016/j.femsle.2004.11.052
92. Pérez-Cobas, A. E., Gosalbes, M. J., Friedrichs, A., Knecht, H., Artacho, A., Eismann, K., et al. (2013). Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 62, 1591-1601. doi: 10.1136/gutjnl-2012-303184
93. Persky, S. E., and Brandt, L. J. (2000). Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am. J. Gastroenterol. 95, 3283-3285. doi: 10.1111/j.1572-0241.2000.03302.x
94. Puzziferri, N., Roshek, T. B. III., Mayo, H. G., Gallagher, R., Belle, S. H., and Livingston, E. H. (2014). Long-term follow-up after bariatric surgery: a systematic review. JAMA 312, 934-942. doi: 10.1001/jama.2014.10706
95. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., et al. (2010). A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65. doi: 10.1038/nature08821
96. Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. (2012). A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60. doi: 10.1038/nature11450
97. Rajilic-Stojanovic, M., Smidt, H., and de Vos, W. M. (2007). Diversity of the human gastrointestinal tract microbiota revisited. Environ. Microbiol. 9, 2125-2136. doi: 10.1111/j.1462-2920.2007.01369.x
98. Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., et al. (2013). Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341:1241214. doi: 10.1126/science.1241214
99. Riemann, L., and Winding, A. (2001). Community dynamics of free-living and particle-associated bacterial assemblages during a freshwater phytoplankton bloom. Microb. Ecol. 42, 274-285. doi: 10.1007/s00248-001-0018-8
100. Schloss, P. D., Gevers, D., and Westcott, S. L. (2011). Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS ONE 6:e27310. doi: 10.1371/journal.pone.0027310
101. Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., et al. (2010). Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18, 190-195. doi: 10.1038/oby.2009.167
102. Sekirov, I., Russell, S. L., Antunes, L. C. M., and Finlay, B. B. (2010). Gut microbiota in health and disease. Physiol. Rev. 90, 859-904. doi: 10.1152/physrev.00045.2009
103. Silverman, M. S., Davis, I., and Pillai, D. R. (2010). Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin. Gastroenterol. Hepatol. 8, 471-473. doi: 10.1016/j.cgh.2010.01.007
104. Sipos, R., Székely, A., Révész, S., and Márialigeti, K. (2010). Addressing PCR biases in environmental microbiology studies. Methods Mol. Biol. 599, 37-58. doi: 10.1007/978-1-60761-439-5_3
105. Smits, L. P., Bouter, K. E. C., de Vos, W. M., Borody, T. J., and Nieuwdorp, M. (2013). Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145, 946-953. doi: 10.1053/j.gastro.2013.08.058
106. Swidsinski, A., Loening-Baucke, V., Lochs, H., and Hale, L. P. (2005). Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J. Gastroenterol. 11, 1131-1140. doi: 10.3748/wjg.v11.i8.1131
107. Tang, W. H., and Hazen, S. L. (2014). The contributory role of gut microbiota in cardiovascular disease. J. Clin. Investig. 124, 4204. doi: 10.1172/JCI72331
108. The Human Microbiome Project Consortium (2012). Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214. doi: 10.1038/nature11234
109. Tack, J., and Deloose, E. (2014). Complications of bariatric surgery: dumping syndrome, reflux and vitamin deficiencies. Best Pract. Res. Clin. Gastroenterol. 28, 741-749. doi: 10.1016/j.bpg.2014.07.010
110. Tehrani, A. B., Nezami, B. G., Gewirtz, A., and Srinivasan, S. (2012). Obesity and its associated disease: a role for microbiota? Neurogastroenterol. Motil. 24, 305-311. doi: 10.1111/j.1365-2982.2012.01895.x
111. Theron, J., and Cloete, T. E. (2000). Molecular techniques for determining microbial diversity and community structure in natural environments. Crit. Rev. Microbiol. 26, 37-57. doi: 10.1080/10408410091154174
112. Tiihonen, K., Ouwehand, A. C., and Rautonen, N. (2010). Human intestinal microbiota and healthy ageing. Ageing Res. Rev. 9, 107-116. doi: 10.1016/j.arr.2009.10.004
113. Tremaroli, V., and Bäckhed, F. (2012). Functional interactions between the gut microbiota and host metabolism. Nature 489, 242-249. doi: 10.1038/nature11552
114. Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., et al. (2014). Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159-166. doi: 10.1038/nm.3444
115. Tsukumo, D. M. L., Carvalho-Filho, M. A., Carvalheira, J. B. C., Prada, P. O., Hirabara, S. M., Schenka, A. A., et al. (2007). Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 56, 1986-1998. doi: 10.2337/db06-1595
116. Turnbaugh, P. J., Backhed, F., Fulton, L., and Gordon, J. I. (2008). Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 3, 213-223. doi: 10.1016/j.chom.2008.02.015
117. Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., et al. (2009). A core gut microbiome in obese and lean twins. Nature 457, 480-484. doi: 10.1038/nature07540
118. Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., and Gordon, J. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031. doi: 10.1038/nature05414
119. Ursell, L. K., Clemente, J. C., Rideout, J. R., Gevers, D., Caporaso, J. G., and Knight, R. (2012). The interpersonal and intrapersonal diversity of human-associated microbiota in key body sites. J. Allergy Clin. Immunol. 129, 1204-1208. doi: 10.1016/j.jaci.2012.03.010
120. Van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., et al. (2013). Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 368, 407-415. doi: 10.1056/NEJMoa1205037
121. Vaughan, E. E., Schut, F., Heilig, H. G., Zoetendal, E. G., de Vos, W. M., and Akkermans, A. D. (2000). A molecular view of the intestinal ecosystem. Curr. Issues Intest. Microbiol. 1, 1-12.
122. Verberkmoes, N. C., Russell, A. L., Shah, M., Godzik, A., Rosenquist, M., Halfvarson, J., et al. (2009). Shotgun metaproteomics of the human distal gut microbiota. ISME J. 3, 179-189. doi: 10.1038/ismej.2008.108
123. Vercellotti, J. R., Salyers, A. A., Bullard, W. S., and Wilkins, D. (1977). Breakdown of mucin and plant polysaccharides in the human colon. Can. J. Biochem. 55, 1190-1196. doi: 10.1139/o77-178
124. Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., et al. (2013). The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342, 971-976. doi: 10.1126/science.1240537
125. Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., et al. (2012). Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913-916.e7. doi: 10.1053/j.gastro.2012.06.031
126. Walker, A. W., Ince, J., Duncan, S. H., Webster, L. M., Holtrop, G., Ze, X., et al. (2011). Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 5, 220-230. doi: 10.1038/ismej.2010.118
127. Walters, W. A., Xu, Z., and Knight, R. (2014). Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 588, 4223-4233. doi: 10.1016/j.febslet.2014.09.039
128. Wang, K., Li, W.-D., Zhang, C. K., Wang, Z., Glessner, J. T., Grant, S. F. A., et al. (2011a). A genome-wide association study on obesity and obesity-related traits. PLoS ONE 6:e18939. doi: 10.1371/journal.pone.0018939
129. Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., Dugar, B., et al. (2011b). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57-63. doi: 10.1038/nature09922
130. Weingarden, A., González, A., Vázquez-Baeza, Y., Weiss, S., Humphry, G., Berg-Lyons, D., et al. (2015). Dynamic changes in short-and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome 3, 10. doi: 10.1186/s40168-015-0070-0
131. Westerbeek, E. A. M., van den Berg, A., Lafeber, H. N., Knol, J., Fetter, W. P. F., and van Elburg, R. M. (2006). The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin. Nutr. 25, 361-368. doi: 10.1016/j.clnu.2006.03.002
132. Whitman, W. B., Coleman, D. C., and Wiebe, W. J. (1998). Prokaryotes: the unseen majority. Proc. Natl. Acad. Sci. U.S.A. 95, 6578-6583. doi: 10.1073/pnas.95.12.6578
133. von Wintzingerode, F., Göbel, U. B., and Stackebrandt, E. (1997). Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol. Rev. 21, 213-229. doi: 10.1111/j.1574-6976.1997.tb00351.x
134. Wooley, J. C., and Ye, Y. (2009). Metagenomics: facts and artifacts, and computational challenges*. J. Comput. Sci. Technol. 25, 71-81. doi: 10.1007/s11390-010-9306-4
135. World Health Organization (2014). Global Status Report on Noncommunicable Diseases. World Health Organization. Available online at: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1
136. Xu, J., Bjursell, M. K., Himrod, J., Deng, S., Carmichael, L. K., Chiang, H. C., et al. (2003). A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299, 2074-2076. doi: 10.1126/science.1080029
137. Yang, X., Xie, L., Li, Y., and Wei, C. (2009). More than 9, 000, 000 unique genes in human gut bacterial community: estimating gene numbers inside a human body. PLoS ONE 4:e6074. doi: 10.1371/journal.pone.0006074
138. Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., et al. (2012). Human gut microbiome viewed across age and geography. Nature 486, 222-227. doi: 10.1038/nature11053
139. Zeitlin, S. B., and Polivy, J. (1995). Coprophagia as a manifestation of obsessive-compulsive disorder: a case report. J. Behav. Ther. Exp. Psychiatry 26, 57-63.
140. Zhang, C., Zhang, M., Wang, S., Han, R., Cao, Y., Hua, W., et al. (2010). Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 4, 232-241. doi: 10.1038/ismej.2009.112
141. Zhang, F., Luo, W., Shi, Y., Fan, Z., and Ji, G. (2012). Should we standardize the 1, 700-year-old fecal microbiota transplantation? Am. J. Gastroenterol. 107, 1755; author reply p.1755-6. doi: 10.1038/ajg.2012.251
142. Zhang, H., DiBaise, J. K., Zuccolo, A., Kudrna, D., Braidotti, M., Yu, Y., et al. (2009). Human gut microbiota in obesity and after gastric bypass. Proc. Natl. Acad. Sci. U.S.A. 106, 2365-2370. doi: 10.1073/pnas.0812600106
143. Zipursky, J. S., Sidorsky, T. I., Freedman, C. A., Sidorsky, M. N., and Kirkland, K. B. (2012). Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin. Infect. Dis. 55, 1652-1658. doi: 10.1093/cid/cis809
144. Zoetendal, E. G., von Wright, A., Vilpponen-Salmela, T., Ben-Amor, K., Akkermans, A. D. L., and de Vos, W. M. (2002). Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol. 68, 3401-3407. doi: 10.1128/AEM.68.7.3401-3407.2002